During the past decade, Crozer-Keystone Regional Cancer Center at Broomall conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Crozer-Keystone Regional Cancer Center at Broomall" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "NRG Oncology" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Crozer-Keystone Regional Cancer Center at Broomall" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Crozer-Keystone Regional Cancer Center at Broomall" are "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (3 trials), "Extensive Stage Lung Small Cell Carcinoma" (2 trials) and "Limited Stage Lung Small Cell Carcinoma" (2 trials). Many other conditions were trialed in "Crozer-Keystone Regional Cancer Center at Broomall" in a lesser frequency.

Most popular intervention types in "Crozer-Keystone Regional Cancer Center at Broomall" are "Drug" (17 trials), "Other" (16 trials), "Radiation" (13 trials), "Procedure" (8 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (6 trials), "Biospecimen Collection" (4 trials), "Computed Tomography" (4 trials) and "Intensity-Modulated Radiation Therapy" (4 trials). Other intervention names were less common.

The vast majority of trials in "Crozer-Keystone Regional Cancer Center at Broomall" are 19 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Crozer-Keystone Regional Cancer Center at Broomall". undefined are not yet recruiting, 8 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Crozer-Keystone Regional Cancer Center at Broomall, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Crozer-Keystone Regional Cancer Center at Broomall, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".